Flash Finance

Eiko Lifesciences Ltd540204Corporate

Specialty Chemicals Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹44.35
MCap ₹70 Cr · P/E 17.8
Eiko Lifesciences Ltd — Stock analysis & AI research Eiko Lifesciences Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹14 Cr
Sales · Jun 2026
+90.3% YoY
₹1 Cr
Operating Profit · Jun 2026
+71.5% YoY
6.4%
OPM % · Jun 2026
-9.9% YoY
₹1 Cr
Net Profit · Jun 2026
+54.3% YoY
₹0.74
EPS · Jun 2026
+48.0% YoY

📝 Eiko Lifesciences Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Eiko Lifesciences Ltd reported revenue of ₹14 crore for the quarter ended June 2026 (Q1 FY27), up 90.3% from ₹7 crore in the same quarter last year, and down 10.8% sequentially over the March 2026 quarter.

Net profit rose 54.3% year-on-year to ₹1 crore, from ₹1 crore. Earnings per share (EPS) came in at ₹0.74.

Operating profit stood at ₹1 crore — an operating margin (OPM) of 6.4%, compared with 7.1% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Eiko Lifesciences Ltd posted revenue of ₹42 crore, a growth of 29.6% over FY25, with a net profit of ₹4 crore (up 105.7% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹49 crore with a net profit of ₹4 crore.

Valuation snapshot

At the current price of ₹44.35, 540204 has a market capitalisation of ₹70 crore and a trailing P/E of about 17.8.

Within the Specialty Chemicals industry, it is the 25th-largest of the 66 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 39.91%, public shareholders 60.09% of Eiko Lifesciences Ltd.

Promoter holding rose from 37.17% to 39.91% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹70 Cr
Current Price ?
₹44.4
P/E ?
17.78below ind
Industry P/E ?
29.60
P/B ?
1.04
P/S ?
1.44
P/FCF ?
97.63
Enterprise Value ?
₹72 Cr
EV/EBITDA ?
19.25
PEG ?
0.26
Earnings Yield ?
4.4%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹49 Cr
OPM ?
7.7%
Profit after tax (TTM) ?
₹4 Cr
EPS (TTM) ?
₹2.50
ROCE ?
7.7%
ROE ?
5.9%
ROA ?
4.8%
Growth
Sales — latest qtr ?
₹14 Cr
PAT — latest qtr ?
₹1 Cr
YoY qtr sales growth ?
90.3%
YoY qtr profit growth ?
54.3%
Sales growth (3y) ?
32%
Sales growth (5y) ?
29%
Profit growth (3y) ?
68%
Profit growth (5y) ?
42%
Financial Health
Debt ?
₹2 Cr
Debt to Equity ?
0.02
Interest Coverage ?
16.2
Current Ratio ?
N/A
Ownership
Promoter holding ?
39.91%
Change in promoter holding ?
3.17%
Pledged percentage ?
N/A
Market
Return 3 months ?
-14.7%
Return 6 months ?
-15.4%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 776781187779101614 +90.3% -10.8%
Operating Profit 00001000111111 +71.5% -26.1%
Other Income 00000000111101 +24.3% +51.9%
Interest 00000000000000 +103.0% +1.5%
Depreciation 00000000000000 -1.7% -1.7%
Profit Before Tax 00000000111111 +54.3% -5.7%
Net Profit 00000000111111 +54.3% -5.0%
EPS 0.200.060.090.170.270.280.170.220.720.500.600.690.780.74 +48.0% -5.1%
OPM % 5.5% 4.1% 5.5% 7.1% 6.1% 3.7% 4.5% 6.5% 7.2% 7.1% 7.9% 9.1% 7.7% 6.4% -9.9% -16.9%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹32 Cr ₹42 Cr ₹49 Cr +29.6%
Operating Profit ₹2 Cr ₹3 Cr ₹4 Cr +96.5%
OPM % 5.26% 7.98% 7.65% +51.7%
NPM % 5.36% 8.50% 8.10% +58.6%
Other Income ₹1 Cr ₹2 Cr ₹2 Cr +55.9%
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr -4.8%
Interest ₹0 Cr ₹0 Cr ₹0 Cr +30.8%
EBIT ₹1 Cr ₹3 Cr ₹3 Cr +155.6%
PBT ₹2 Cr ₹5 Cr ₹5 Cr +103.9%
Tax — — ₹0 Cr —
Net Profit ₹2 Cr ₹4 Cr ₹4 Cr +105.7%
EPS ₹1.39 ₹2.57 ₹2.81 +84.9%
Material Cost — — ₹13 Cr —
Employee Cost — — ₹0 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 8.3212.8713.7614.35 +4.3%
Reserves 21.1137.8142.6653.15 +24.6%
Borrowings 0.050.001.751.67 -4.6%
Other Liabilities 1.572.062.2113.62 +516.3%
Total Liabilities 31.0552.7460.3882.79 +37.1%
Fixed Assets 13.8813.5714.2613.67 -4.1%
CWIP 0.000.000.000.00 —
Investments 0.054.027.0715.15 +114.3%
Other Assets 17.1235.1539.0553.97 +38.2%
Total Assets 31.0552.7460.3882.79 +37.1%

💧 Cash Flow (latest 4 periods)

Metric Mar 2022Mar 2023Mar 2024Mar 2025 % Chg
Cash from Operating Activity -7.734.22-7.082.05 +129.0%
Cash from Investing Activity 0.590.87-0.55-9.85 -1690.9%
Cash from Financing Activity 3.28-4.7020.365.97 -70.7%
Net Cash Flow -3.850.4012.73-1.83 -114.4%
Free Cash Flow -7.884.00-7.430.72 +109.7%
CFO/OP -574%427%-435%137% +131.5%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 141.66171.59113.92163.66 +43.7%
Inventory Days 20.6448.7050.2338.86 -22.6%
Days Payable 23.8219.8213.87121.67 +777.2%
Cash Conversion Cycle 138.48200.46150.2880.85 -46.2%
Working Capital Days 149.23210.14164.4789.84 -45.4%
ROCE % 3.70%2.84%3.84%7.65% +99.2%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 36.74%37.17%37.17%39.91% +7.4%
Public 63.26%62.81%62.83%60.09% -4.4%
No. of Shareholders 3,3223,1503,0922,969 -4.0%

⚖️ Peer comparison

Industry: Specialty Chemicals · top 25 of 66 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 ASIANPAINT Asian Paints ₹2,472.50 237,025 49.8 37,152 4,798 19.5% 12.9% 5.1% 18.0% 18.1% 41.8%
2 SOLARINDS Solar Industries ₹22,290.00 201,702 101.3 11,351 2,051 27.3% 18.1% 30.3% 34.9% 70.3% 89.0%
3 PIDILITIND Pidilite Industries ₹1,566.90 159,492 60.2 15,399 2,676 24.5% 17.4% 11.1% 17.9% 21.3% 30.3%
4 BERGEPAINT Berger Paints ₹458.50 53,461 43.9 12,263 1,218 15.6% 9.9% 2.9% -4.7% 12.0% 28.6%
5 LINDEINDIA Linde India ₹6,250.00 53,303 97.6 2,654 546 34.4% 20.6% 1.8% 20.8% 21.6% -2.4%
6 FLUOROCHEM Gujarat Fluorochemicals ₹4,773.00 52,431 85.7 5,303 609 25.9% 11.5% 5.5% 5.1% 24.0% 19.0%
7 HSCL Himadri Speciality ₹664.25 33,516 41.6 4,974 805 20.2% 16.2% 1.0% 36.2% 28.0% 27.4%
8 ACUTAAS Acutaas Chemicals ₹3,163.20 25,897 67.1 1,462 387 37.2% 26.5% 33.0% 121.8% 59.1% 70.4%
9 AETHER Aether Industries ₹1,792.00 23,785 108.3 1,153 219 31.4% 19.0% 37.5% 38.8% 27.1% 8.0%
10 ATUL Atul ₹6,250.50 18,403 23.1 6,643 811 17.4% 12.2% 12.4% 38.2% 25.0% 91.8%
11 AARTIIND Aarti Industries ₹470.80 17,078 32.2 9,011 531 14.8% 5.9% 14.1% 26.6% 42.4% 260.5%
12 BASF BASF India ₹3,669.00 15,882 24.7 16,041 643 5.9% 4.0% -1.1% -12.4% 24.5% 163.0%
13 FINEORG Fine Organic ₹5,170.50 15,853 36.2 2,471 438 21.6% 17.7% 4.2% 1.5% 18.0% 18.0%
14 SPLPETRO Supreme Petrochem ₹820.50 15,429 32.0 5,644 482 12.9% 8.5% -11.4% -16.1% 22.1% 192.1%
15 KANSAINER Kansai Nerolac ₹188.79 15,269 25.4 8,264 589 12.1% 7.1% 2.9% -48.1% 9.8% 5.9%
16 PRIVISCL Privi Speciality ₹3,551.10 13,872 39.7 2,672 342 24.9% 12.8% 22.0% 71.1% 19.2% 44.2%
17 ANURAS Anupam Rasayan ₹1,153.90 13,137 74.3 2,535 225 22.2% 8.9% 64.5% 39.1% 34.8% 5.7%
18 VINATIORGA Vinati Organics ₹1,253.90 13,008 29.0 2,381 449 27.9% 18.8% -1.0% 9.6% 28.4% 4.5%
19 500123 Elantas Beck ₹13,869.00 10,995 61.9 937 177 23.2% 18.9% 11.1% 6.6% 34.8% 82.1%
20 PRASOLCHEM Prasol Chemicals ₹791.80 4,686 — — — — — — — 35.5% 154.3%
21 JUBLCPL Jubilant Agri ₹2,117.00 3,208 24.7 1,972 130 10.2% 6.6% — — 18.4% 4.8%
22 504092 Indokem ₹86.92 1,695 107.3 174 2 3.0% 1.3% -4.9% -41.1% 12.2% 52.9%
23 524717 Titan Biotech ₹576.80 1,681 70.3 219 34 19.4% 15.5% 31.8% 38.7% 27.2% 58.3%
24 PAUSHAKLTD Paushak ₹651.65 1,607 34.0 277 48 28.9% 17.2% 4.3% -18.4% 51.4% 50.1%
25 540204 Eiko Lifesciences ₹63.96 70 18.3 59 6 13.4% 9.8% 39.9% 129.7% 56.4% 35.9%
❓ Frequently asked questions
What was Eiko Lifesciences Ltd's revenue in Q1 FY27?
Eiko Lifesciences Ltd reported revenue of ₹14 crore for the quarter ended June 2026 (Q1 FY27), up 90.3% from ₹7 crore in the same quarter last year, and down 10.8% sequentially over the March 2026 quarter.
What was Eiko Lifesciences Ltd's net profit in Q1 FY27?
Net profit rose 54.3% year-on-year to ₹1 crore, from ₹1 crore. Earnings per share (EPS) came in at ₹0.74.
What is 540204's market capitalisation and P/E ratio?
At the current price of ₹44.35, 540204 has a market capitalisation of ₹70 crore and a trailing P/E of about 17.8.
Who owns Eiko Lifesciences Ltd? (shareholding pattern)
As of Mar 2026, promoters held 39.91%, public shareholders 60.09% of Eiko Lifesciences Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI